137 related articles for article (PubMed ID: 33605471)
1. Increased lipoxygenase and decreased cytochrome P450s metabolites correlated with the incidence of diabetic nephropathy: Potential role of eicosanoids from metabolomics in type 2 diabetic patients.
Peng L; Sun B; Liu Y; Huang J; Chen G; Zhang X; Chen C; Wang D; Wang G
Clin Exp Pharmacol Physiol; 2021 May; 48(5):679-685. PubMed ID: 33605471
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics revealed decreased level of omega-3 PUFA-derived protective eicosanoids in pregnant women with pre-eclampsia.
Liu Y; Zu L; Cai W; Cheng Q; Hua T; Peng L; Li G; Zhang X
Clin Exp Pharmacol Physiol; 2019 Aug; 46(8):705-710. PubMed ID: 30983029
[TBL] [Abstract][Full Text] [Related]
3. 5-Hydroxyhexanoic Acid Predicts Early Renal Functional Decline in Type 2 Diabetes Patients with Microalbuminuria.
Tang X; You J; Liu D; Xia M; He L; Liu H
Kidney Blood Press Res; 2019; 44(2):245-263. PubMed ID: 31071709
[TBL] [Abstract][Full Text] [Related]
4. Acyl ethanolamides in Diabetes and Diabetic Nephropathy: Novel targets from untargeted plasma metabolomic profiles of South Asian Indian men.
Devi S; Nongkhlaw B; Limesh M; Pasanna RM; Thomas T; Kuriyan R; Kurpad AV; Mukhopadhyay A
Sci Rep; 2019 Dec; 9(1):18117. PubMed ID: 31792390
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic study of the protective effect of Gandi capsule for diabetic nephropathy.
Liu Y; Chen X; Liu Y; Chen T; Zhang Q; Zhang H; Zhu Z; Chai Y; Zhang J
Chem Biol Interact; 2019 Dec; 314():108815. PubMed ID: 31499054
[TBL] [Abstract][Full Text] [Related]
6. Monocyte-lymphocyte ratio is a valuable predictor for diabetic nephropathy in patients with type 2 diabetes.
Huang Q; Wu H; Wo M; Ma J; Fei X; Song Y
Medicine (Baltimore); 2020 May; 99(19):e20190. PubMed ID: 32384513
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological characteristics of non-diabetic renal disease in patients with type 2 diabetes mellitus in a northeastern Chinese medical center: a retrospective analysis of 273 cases.
Liu S; Guo Q; Han H; Cui P; Liu X; Miao L; Zou H; Sun G
Int Urol Nephrol; 2016 Oct; 48(10):1691-8. PubMed ID: 27272256
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors for non-diabetic nephropathy in diabetic patients. The utility of renal biopsy.
Bermejo S; Soler MJ; Gimeno J; Barrios C; Rodríguez E; Mojal S; Pascual J
Nefrologia; 2016; 36(5):535-544. PubMed ID: 27523263
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of circulating microRNA-126 in patients with type 2 diabetic nephropathy: A potential blood-based biomarker.
Al-Kafaji G; Al-Mahroos G; Al-Muhtaresh HA; Skrypnyk C; Sabry MA; Ramadan AR
Exp Ther Med; 2016 Aug; 12(2):815-822. PubMed ID: 27446281
[TBL] [Abstract][Full Text] [Related]
10. Association of Dietary Fish and n-3 Unsaturated Fatty Acid Consumption with Diabetic Nephropathy from a District Hospital in Northern Taiwan.
Lin SP; Chen CM; Wang KL; Wu KL; Li SC
Nutrients; 2022 May; 14(10):. PubMed ID: 35631289
[TBL] [Abstract][Full Text] [Related]
11. Predictive metabolic signatures for the occurrence and development of diabetic nephropathy and the intervention of Ginkgo biloba leaves extract based on gas or liquid chromatography with mass spectrometry.
Du Y; Xu BJ; Deng X; Wu XW; Li YJ; Wang SR; Wang YN; Ji S; Guo MZ; Yang DZ; Tang DQ
J Pharm Biomed Anal; 2019 Mar; 166():30-39. PubMed ID: 30599279
[TBL] [Abstract][Full Text] [Related]
12. Comparison of intrarenal renin-angiotensin system activity in diabetic versus non-diabetic patients with overt proteinuria.
Park JH; Jang HR; Lee JH; Lee JE; Huh W; Lee KB; Kwon YJ; Do JY; Kim HY; Kim YG
Nephrology (Carlton); 2015 Apr; 20(4):279-85. PubMed ID: 25522682
[TBL] [Abstract][Full Text] [Related]
13. Expression of microRNA‑377 and microRNA‑192 and their potential as blood‑based biomarkers for early detection of type 2 diabetic nephropathy.
Al-Kafaji G; Al-Muhtaresh HA
Mol Med Rep; 2018 Jul; 18(1):1171-1180. PubMed ID: 29845236
[TBL] [Abstract][Full Text] [Related]
14. Kruppel-Like Transcription Factor-4 Gene Expression and DNA Methylation Status in Type 2 Diabetes and Diabetic Nephropathy Patients.
Coskun ZM; Ersoz M; Adas M; Hancer VS; Boysan SN; Gonen MS; Acar A
Arch Med Res; 2019 Apr; 50(3):91-97. PubMed ID: 31495395
[TBL] [Abstract][Full Text] [Related]
15. Peripheral blood mitochondrial DNA copy number as a novel potential biomarker for diabetic nephropathy in type 2 diabetes patients.
Al-Kafaji G; Aljadaan A; Kamal A; Bakhiet M
Exp Ther Med; 2018 Aug; 16(2):1483-1492. PubMed ID: 30116398
[TBL] [Abstract][Full Text] [Related]
16. Assessment of two novel renal tubular proteins in type 2 diabetic patients with nephropathy.
Abdel Ghafar MT; Shalaby KH; Okda HI; Abo El Gheit RE; Soliman NA; Keshk WA
J Investig Med; 2020 Mar; 68(3):748-755. PubMed ID: 31722957
[TBL] [Abstract][Full Text] [Related]
17. [Correlation between cognitive impairment and diabetic nephropathy in patients with Type 2 diabetes mellitus].
Shi X; Zhang Y; Niu H; Wang R; Shen J; Zhou S; Yang H; Wang S; Wu J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 41(2):143-50. PubMed ID: 26932211
[TBL] [Abstract][Full Text] [Related]
18. Metabolomics window into the role of acute kidney injury after coronary artery bypass grafting in diabetic nephropathy progression.
Wang J; Yan W; Zhou X; Liu Y; Tang C; Peng Y; Liu H; Sun L; Xiao L; He L
PeerJ; 2020; 8():e9111. PubMed ID: 32461830
[TBL] [Abstract][Full Text] [Related]
19. Diabetic retinopathy is a poor predictor of type of nephropathy in proteinuric type 2 diabetic patients.
Prakash J; Lodha M; Singh SK; Vohra R; Raja R; Usha
J Assoc Physicians India; 2007 Jun; 55():412-6. PubMed ID: 17879494
[TBL] [Abstract][Full Text] [Related]
20. Plasma metabolic profile reveals PGF2α protecting against non-proliferative diabetic retinopathy in patients with type 2 diabetes.
Peng L; Sun B; Liu M; Huang J; Liu Y; Xie Z; He J; Chen L; Wang D; Zhu Y; Zhang X; Ai D
Biochem Biophys Res Commun; 2018 Feb; 496(4):1276-1283. PubMed ID: 29408756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
